Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Trading 02-25 15:20:38 EST

2,024.64

-10.01

-0.49%

High2,055.90	Low2,017.60	Vol12.12M
Open2,034.75	D1 Closing2,034.66	Amplitude1.88%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O748.50M	T/O Rate--	Tradable Shares0.00
P/B4.962837	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2024.6433,"timestamp":1772050838541,"preClose":2034.6571,"halted":0,"volume":12122527,"delay":0,"changeRate":-0.004922,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-10.013794,"latestTime":"02-25 15:20:38 EST","open":2034.7506,"high":2055.899,"low":2017.5997,"amount":748502353.041495,"amplitude":0.018823,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.962837,"peRate":39.999588,"turnoverRate":0.004523,"increases":6,"decrements":4,"flats":0,"marketCap":224988683766.5,"floatMarketCap":224368816374},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2614058429","title":"What to Watch in the Day Ahead - Thursday, February 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2614058429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614058429?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:34","pubTimestamp":1772048076,"startTime":"0","endTime":"0","summary":"What to Watch in the Day Ahead - Thursday, February 26The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ah","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL6N3ZL11X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827948.USD","LU1815333072.USD","BK4560","LU0979878070.USD","DLLL","VTRS","LU1674673691.USD","PEG","LU0266013472.USD","LU1201861249.SGD","LU0128525689.USD","LU0505663152.USD","BK4139","LU1037948897.HKD","LU0097036916.USD","LU0965509010.AUD","BK4208","BK4608","LU0738911758.USD","BK4213","BK4122","LU0889565833.HKD","LU0130517989.USD","BK4535","LU2362541273.HKD","CRWG","BK4220","SG9999002232.USD","LU0011850046.USD","IE0009356076.USD","IE00B29SXK94.USD","LU2065171311.SGD","LU2362540622.SGD","GB00BDT5M118.USD","CRWU","LU0211326839.USD","LU1235294995.USD","LU2023251221.USD","BK4097","LU0211326755.USD","IE00BMG7P926.USD","LU2210150020.SGD","LU0965508806.USD","LU1121112475.USD","BK4547","LU0965509283.SGD","BK4581","LU0861579265.USD","LU2089284900.SGD","LU1043141396.HKD","LU2065170008.USD","BK4567","LU2095319765.USD","BK4543","LU1778281490.HKD","LU1823568750.SGD","IE00BD4GTW91.USD","LU0289961442.SGD","LU1236620750.USD","LU0957791311.USD","LU1242518931.SGD","LU1839511570.USD","LU0342679015.USD","BK4116","LU1923622291.USD","HRL","BK4533","LU0048573561.USD","LU2125909759.SGD","INTU","LU0052756011.USD","LU2089283258.USD","IE00B29SXL02.USD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","LU0823434740.USD","LU0300736492.USD","SG9999001424.SGD","LU2346227817.USD","LU2362541513.USD","IE000M9KFDE8.USD","CTRA","LU0109392836.USD","LU1267930227.SGD","LU0157215616.USD","LU1674673428.USD","LU0289739343.SGD","IE00B19Z8X17.USD","BK4613","LU0426412945.USD","LU0823434583.USD","MP","BK4170","BK4588","IE00BQXX3F31.USD","LU0980610538.SGD","NVAX","LU1804176565.USD","LU1037948541.HKD","IE00B19Z8W00.USD","LU1934455863.HKD","LU1366333091.USD","BK4528","IE00BD6J9T35.USD","LU0251142724.SGD","WBD","LU2384288077.EUR","LU1621768206.USD","LU0648001328.SGD","LU2065169927.USD","MPG","SG9999002224.SGD","LU2265009873.SGD","ZS","IE00BMG7P819.SGD","IE00B19Z9505.USD","LU1934455194.USD","BK4548","LU0124676726.USD","DUOL","BK4568","LU0477156953.USD","LU2087621335.USD","BK4583","LU0976567544.SGD","LU2125909916.SGD","LU0345774631.USD","LU1236620834.HKD","BK4585","BK4108","LU0149725797.USD","LU0082616367.USD","BK4504","LU0426417589.USD","LU0719512351.SGD","LU1242518857.USD","LU2210149790.SGD","BK4168","LU0251131958.USD","LU1621767737.EUR","LU0949170772.SGD","BK4534","SRE","RY","SG9999001440.SGD","BK4212","MPL","LU0742534661.SGD","BK4023","IE00BMG7P587.USD","LU0496365809.HKD","LU0267386448.USD","SJM","LU1803068979.SGD","LU0994945656.USD","LU2286300806.USD","IE00B5949003.HKD","LU0345774391.USD","LU0640476718.USD","LU1621768115.EUR","IE00BMG7P694.USD","LU2063271972.USD","LU0661504455.SGD","CWVX","BK4598","LU1280957306.USD","CPNG","BK4007","LU0689626769.HKD","LU0965509101.SGD","LU0238689110.USD","BK4515","LU1046421795.USD","LU0511384066.AUD","IE00BD4GTT62.SGD","BK4539","BK4125","IE00BD4GTV84.USD","LU0130102774.USD","LU2449327464.USD","LU0390134368.USD","LU2065171402.SGD","LU1043141123.HKD","LU1621767810.EUR","LU1934455277.USD","BK4204","BK4551","LU0061474960.USD","LU0300736062.USD","LU0256331488.USD","LU0310800965.SGD","DELL","CORD"],"gpt_icon":1},{"id":"2614058592","title":"Gilead Says HIV Treatment Trial Results Show Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2614058592","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614058592?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:08","pubTimestamp":1772046480,"startTime":"0","endTime":"0","summary":"Gilead Sciences posted results from a Phase 3 trial showing its HIV treatment was effective.The trial of bictegravir 75 mg/lenacapavir 50 mg was also well-tolerated and demonstrated the potential to broaden into options for adults with virological suppression, the company said.The Foster City, Calif., company said the treatment offered comparable efficacy to Biktarvy and treatment with complex multi-tablet regimens.\"We look forward to working with regulatory authorities to potentially bring this combination forward to people with HIV,\" said Jared Baeten, Gildead's virology therapeutic head.Bictegravir and lenacapavir in combination are investigational and not approved anywhere globally.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","IE00B19Z3B42.SGD","BK4585","IE00BKVL7J92.USD","LU0882574055.USD","LU1430594728.SGD","BK4139","BK4532","LU1066053197.SGD","SG9999015945.SGD","LU2089984988.USD","IE0002270589.USD","LU0058720904.USD","LU0889565916.HKD","LU1037948541.HKD","LU0114720955.EUR","BK4568","LU1839511570.USD","IE00BSNM7G36.USD","SG9999015978.USD","LU2087621335.USD","LU1066051498.USD","LU1571399168.USD","BK4588","LU0965509283.SGD","LU0320765992.SGD","BK4578","LU1037948897.HKD","IE00B7SZLL34.SGD","BK4583","LU0965509010.AUD","LU1585245621.USD","LU1674673428.USD","SG9999015986.USD","SG9999015952.SGD","BK4550","LU1023059063.AUD","LU0861579265.USD","LU1057294990.SGD","LU1061106388.HKD","LU2112291526.USD","BK4566","GILD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1778281490.HKD","LU0122379950.USD","LU1674673691.USD","LU0234570918.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2614305833","title":"Gilead presents new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2614305833","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614305833?lang=en_us&edition=fundamental","pubTime":"2026-02-26 02:51","pubTimestamp":1772045480,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at CROI 2026 showing a treatment switch to an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-presents-new-phase-3-artistry-1-and-artistry-2-trial-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-presents-new-phase-3-artistry-1-and-artistry-2-trial-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","LU0965509101.SGD","LU1839511570.USD","LU1674673428.USD","BK4588","IE00B3T34201.USD","SG9999015952.SGD","BK4566","LU0320765992.SGD","LU0965509283.SGD","LU2324357040.USD","LU0965509010.AUD","LU1057294990.SGD","GILD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU2112291526.USD","LU0882574055.USD","LU0823416689.USD","LU2089984988.USD","SG9999015986.USD","LU1571399168.USD","LU0234570918.USD","BK4139","LU0889565916.HKD","IE00BKVL7J92.USD","IE0002270589.USD","LU0965508806.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU0122379950.USD","BK4532","LU1037948897.HKD","BK4550","IE00BZ1G4Q59.USD","LU0861579265.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1066051498.USD","SG9999015978.USD","LU1430594728.SGD","LU1023059063.AUD","BK4583","LU0058720904.USD","LU1037948541.HKD","LU1585245621.USD","LU2468319806.SGD","BK4585","SG9999015945.SGD"],"gpt_icon":0},{"id":"2614032765","title":"Merck's New HIV Drug Shows Promise. Its Chief Medical Officer Explains Why Wall Street Should Care. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2614032765","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614032765?lang=en_us&edition=fundamental","pubTime":"2026-02-26 01:38","pubTimestamp":1772041080,"startTime":"0","endTime":"0","summary":"With years to go before Merck loses patent protection for its biggest revenue driver, all eyes are on the company to find a new miracle drug. It seems Merck may be on the right path.On Wednesday, the drugmaker presented results from Phase 3 trials evaluating the efficacy of its once-daily, oral regimen of doravirine and islatravir in adults with HIV-1. The trial evaluated the regimen's success in preventing HIV-1 replication using viral load, a measure of the amount of HIV genetic material in the blood.The two-drug regimen was compared with Biktarvy, a three-drug regimen from Gilead Sciences, in a patient population that hadn't previously received antiretroviral treatment.\"Competition is not a dirty word,\" Barr said. \"It is a terrific stimulant of a sense of urgency.\" Merck's \"credo\" is that \"if it's good for the patient, it's good for the company and ultimately it's good for the shareholder,\" he added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4566","LU0432979614.USD","IE00BN8TJ469.HKD","LU0109394709.USD","LU1699723380.USD","IE0002270589.USD","LU1934455277.USD","LU2324357040.USD","BK4559","LU0130102774.USD","LU0965509283.SGD","BK4516","LU1023059063.AUD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0965508806.USD","LU0098860793.USD","BK4534","SG9999015945.SGD","BK4533","IE00BJJMRZ35.SGD","LU1585245621.USD","IE00BLSP4452.SGD","LU1116320901.HKD","BK4578","LU1941712348.USD","LU1974910355.USD","SG9999015986.USD","IE00B19Z3B42.SGD","LU0882574055.USD","LU1571399168.USD","LU1989772923.USD","LU1674673691.USD","MRK","LU1674673428.USD","IE00BJT1NW94.SGD","LU1116320737.USD","LU1093756325.SGD","LU0289739699.SGD","LU0320765646.SGD","LU0648001328.SGD","BK4583","LU1941712264.USD","LU0980610538.SGD","LU2125154935.USD","IE00BSNM7G36.USD","BK4007","LU2361044865.SGD","IE000M9KFDE8.USD","LU1983299246.USD","BK4550","LU1066053197.SGD","LU1066051498.USD","SG9999015978.USD","LU1061106388.HKD","BK4532","SG9999014567.USD","SGXZ57979304.SGD","BK4585","SG9999001176.SGD","LU1778281490.HKD","IE00BKVL7J92.USD","LU1093756168.USD","LU0106261372.USD","IE0002141913.USD","LU1069347547.HKD","IE0009355771.USD","LU0265550946.USD","LU1162221912.USD","IE00BLSP4239.USD","LU0208291251.USD","LU2468319806.SGD","IE00BBT3K403.USD","IE00BZ1G4Q59.USD","LU0211331839.USD","BK4568","LU0006306889.USD","LU2112291526.USD","SG9999014559.SGD","LU1066051225.USD","LU0823416689.USD","SG9999001176.USD","LU0203347892.USD","SG9999002224.SGD","LU1929549753.HKD","IE00B3T34201.USD","IE00B2B36J28.USD","LU0234572021.USD","LU0861579265.USD","LU1934455863.HKD","GILD","LU1989772840.SGD","LU1066051811.HKD","LU1201861249.SGD","LU2023250504.SGD","LU1057294990.SGD","SG9999015358.SGD","LU0114720955.EUR","LU2361044949.HKD","LU0266013472.USD","LU2360032135.SGD","LU0985320562.USD","LU2361045086.USD","LU1989771016.USD","LU2125154778.USD","LU0320765992.SGD","LU0070302665.USD","LU0265550359.USD","LU2106854487.HKD","SG9999015952.SGD","LU1934455194.USD","LU0477156953.USD","LU2461242641.AUD","LU0058720904.USD","LU0965509101.SGD","LU1035773651.USD","SG9999013999.USD","LU1291159041.SGD","LU0965509010.AUD","LU1430594728.SGD","LU2023250843.SGD","SG9999014575.USD","SG9999015341.SGD","IE00B1BXHZ80.USD","LU0122379950.USD","IE00B19Z3581.USD","SG9999002232.USD","BK4139","SG9999014542.SGD","LU0238689110.USD","LU1037948541.HKD","LU1839511570.USD","IE00B7SZLL34.SGD","LU0130517989.USD","LU2087621335.USD","IE00BFTCPJ56.SGD","LU0234570918.USD","BK4588","LU0320765489.SGD","LU1917777945.USD","LU1037948897.HKD","SG9999001440.SGD","LU0203345920.USD"],"gpt_icon":0},{"id":"2614039937","title":"BUZZ-U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039937","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614039937?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:46","pubTimestamp":1772034406,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, ApplovinEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL6N3ZL107:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565833.HKD","LU2275660780.HKD","LU0124384867.USD","LU0208291251.USD","LU0353189680.USD","LU0868494617.USD","LU1935042488.USD","LU2543165471.USD","LU1691799644.USD","LU0823417653.USD","LU2746668974.SGD","LU0210536198.USD","BK4532","BK4183","LU0006061336.USD","LU1839511570.USD","LU1804176565.USD","LU1429558221.USD","LU2272731600.USD","LU1548497426.USD","IE00B19Z3581.USD","LU0314106906.USD","LU1992135472.HKD","LU1267930730.SGD","LU1435385759.SGD","LU0175139822.USD","LU0345781412.USD","LU0323240290.USD","LU2210149790.SGD","LU1244550494.USD","LU1037948897.HKD","LU0130102774.USD","LU2237443465.HKD","HUTG","ORCS","LU0266512127.USD","LU0823434583.USD","IE00BMPRXQ63.HKD","LU1489326972.SGD","LU0612318385.USD","LU0300736062.USD","LU0965508806.USD","LU1934455194.USD","LU2498475776.HKD","BK4583","BK4097","BK4533","IE00BMPRXN33.USD","LU2237957902.USD","LU1778281490.HKD","LU1861217088.USD","BK4015","LU1861219969.SGD","LU0106831901.USD","BK4121","LU0868494708.USD","LU0345780950.USD","LU0950375773.USD","LU2491050071.SGD","BK4008","ALBG","LU0719512351.SGD","LU1244550221.USD","IE0009356076.USD","LU0456854461.SGD","LU1823568750.SGD","BK4588","LU0444973449.USD","ICRC","LU0128525929.USD","BK4570","LCIZ","LU2250418816.HKD","LU2237443382.USD","BK4157","LU0654597011.USD","BK4528","IE00B775SV38.USD","LU2211814178.USD","LU1974910355.USD","LU0154245673.USD","LU2272731865.HKD","LU0672654240.SGD","BK4585","LU1674673691.USD","IE0009354923.USD","LU1035773651.USD","IE00BD6J9T35.USD","LU2360108059.USD","IE00BN0W2W23.USD","LU1803068623.USD","LU0791590937.USD","LU2087625088.SGD","BK4504","LU0788109121.HKD","LU0314104364.USD","LU1989764748.USD","BK4146","IE00B19Z9P08.USD","LU0234570918.USD","LU1935042991.SGD","FCXG","LU0823417737.USD","LU2506952170.USD","BK4082","LU1720051108.HKD","BK4596","LU0300736492.USD","LU1201861249.SGD","JOBX","LU2272731782.SGD","BK4196","LU0056508442.USD","IE00B3S45H60.SGD","LU0878866978.SGD","LU1894683264.USD","LU1720051017.SGD","LU0889566641.SGD","LU1169589451.USD","IE0002270589.USD","LU1366334651.USD","LU2054465674.USD","LU1023059493.AUD","LU2326559502.SGD","LU0266512473.USD","LU2746668461.USD","BK4109","LU0823414551.USD","ORCU","LU2322448957.HKD","BK4534","LU2237443549.SGD","BK4094","LU1074936037.SGD","LU0050427557.USD","LU0075056555.USD","LU2249611893.SGD","LU0109392836.USD","LU0330918003.SGD","LU2360106780.USD","LU2380233275.USD","LU2265009873.SGD","IE00BMPRXR70.SGD","BK4543","LU0823421416.USD","BK4519","LU1623119135.USD","BK4545","BK4551","LU0278409577.USD","LU1935042215.USD","LU1223082519.USD","BK4613","IE00BLSP4452.SGD","LU2133065610.SGD","LU0738911758.USD","CRCD","IE0004445239.USD","IE00B5TLWC47.USD","LU2023250504.SGD","LU2462611646.USD","LU0791591158.USD","LU0081259029.USD","BK4538","LU1366333091.USD","BK4198","IE00B19Z3B42.SGD","LU2506951875.HKD","LU2896262040.SGD","BK4539","LU1992135399.USD","BK4210","LU0788109048.HKD","LU0792757196.USD","LU1267930813.SGD","BK4209","LU2063271972.USD","LU0823421333.USD","SG9999003800.SGD","LU2237443895.HKD","LU0070302665.USD","LU2095319765.USD","LU2517655028.SGD","LU1934455863.HKD","LU0724618433.USD","BK4187","BK4093","IE0034235188.USD","STSS","LU2211815571.USD","LU1861220207.SGD","LU1917777945.USD","LU2322448791.USD","LU1712237335.SGD","LU0942090050.USD","LU0985489474.SGD","LU0302445910.USD","LU0198837287.USD","LU2087621335.USD","LU1803068979.SGD","IE00BLSP4239.USD","LCDL","IE00BZ9MQY76.HKD","IE00BN0W2V16.EUR","LU1935043023.USD","LU2237438978.USD","CCUP","LU0433182093.SGD","LU1935043536.SGD","IE00BGHQF417.EUR","LU2860962120.EUR","LU0109391861.USD","BK4602","LU0256863811.USD","IE00B5949003.HKD","LU0094547139.USD","LU1267930573.SGD","LU1983299162.USD","LU1046421795.USD","LU2092937221.SGD","SG9999001424.SGD","LU0980610538.SGD","LU1934455277.USD","LU1668664300.SGD","BK4141","LU0505663152.USD","LU0957808578.USD","LU0234572021.USD","LU2237957811.SGD","BK4017","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0082616367.USD","LU0312595415.SGD","LU0154245756.USD","LU2298322129.HKD","LU1883866441.USD","IE00B19Z9Z06.USD","SG9999000418.SGD","BK4566","LU0786609619.USD","LU1878469433.USD","LU2491049909.HKD","IE00BN0W2T93.GBP","LU0630314457.HKD","LU0823414478.USD","LU1978683503.SGD","LU2048586759.USD","BK4548","LU0476273544.USD","LU0949170772.SGD","LU0648001328.SGD","LU2210150020.SGD","LUNL","LU1223082196.USD","LU1003077747.HKD","BK4597","LU2357125470.USD","LU0320765489.SGD","LU0072461881.USD","BK4595","LU0320765059.SGD","LU2236285917.USD","LU2298321311.HKD","LU0162691827.USD","LU1642822529.SGD","LU2506951792.HKD","LU0861579265.USD","LU1989772923.USD","ORCX","LU1815336760.USD","LU0310800379.SGD","LU0417517546.SGD","LU2237443622.USD","LU2294711713.HKD","BK4535","LU0823434740.USD","LU2458330169.SGD","LU2473716301.USD","BK4170","SG9999011175.SGD","LU0965509010.AUD","LU0612318971.USD","LU1223083913.SGD","LU0157215616.USD","LU0353189763.USD","CRCA","LU1506573853.SGD","LU0345780521.USD","LU1235294995.USD","LU1037948541.HKD","BK4603","SG9999002521.SGD","BK4116","LU1989772840.SGD","BK4592","LU0289960550.SGD","IE00B2PGVK34.USD","LU0132412106.USD","LU1791807156.HKD","LU0348723411.USD","LU1430597077.USD","LU1852331112.SGD","LU2517655291.USD","LU2237443978.SGD","LU0107464264.USD","LU0708995401.HKD","BK4600","BK4191","IE00B1BXHZ80.USD","LU1366334578.USD","LU0965509283.SGD","BK4083","LU0553294199.USD","IE000M9KFDE8.USD","LU0072463663.USD","BK4023","BK4515","BK4099","LU0708994859.HKD","LU2517655374.HKD","LU2357305700.SGD","IE00B3CCJ633.GBP","IE00BN8TJ469.HKD","LU2458330243.SGD","LU1861214812.USD","LU1069347547.HKD","LU1366192091.USD","LU0572108347.SGD","LU1674673428.USD","LU0323239441.USD","LU0444971666.USD","LU0029864427.USD","LU2106854487.HKD","LU0345780281.USD","BK4007","CRCO","LU2108987350.USD","BK4555","IE00BBT3K403.USD","BK4581","LU2041044095.USD","IE00B894F039.SGD","LU1989773731.SGD","APP","LU1989763005.USD","LU1169590202.USD","LU2491050154.USD","LU0068578508.USD","LU2506951958.HKD","LU1989764664.SGD","BK4516","LU2506952097.USD","LU0661504455.SGD","LU2360107671.USD","LU1894683348.USD","BK4139","LU0323591593.USD","LU0545039389.USD","CRCG","WHR","LU1244550577.SGD","IE00BFMHRM44.USD"],"gpt_icon":1},{"id":"2614403682","title":"Quest Diagnostics CFO Sam Samad to Speak at Leerink 2026 Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614403682","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614403682?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:00","pubTimestamp":1772031641,"startTime":"0","endTime":"0","summary":"Quest Diagnostics CFO Sam Samad to Speak at Leerink 2026 Global Healthcare Conference               Quest Diagnostics said Sam Samad, executive vice president and chief financial officer, will speak i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL6cckqT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU2506951875.HKD","LU2506952170.USD","LU0823417737.USD","LU0950375773.USD","LU0823417653.USD","LU2506951958.HKD","DGX","BK4567","LU1854103824.USD","BK4585","LU1854104046.USD","LU2506952097.USD","BK4588","BK4583"],"gpt_icon":0},{"id":"2614810950","title":"BUZZ-Viatris rises as FDA begins review of eye drop for age‑related near‑vision loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2614810950","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614810950?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:24","pubTimestamp":1772022241,"startTime":"0","endTime":"0","summary":"BUZZ-Viatris rises as FDA begins review of eye drop for agerelated nearvision loss** Shares of generic drugmaker Viatris VTRS.O rise 1.5% to $16.31 premarket ** Co says FDA accepted its application to expand Ryzumvi’s use for the treatment of presbyopia, an agerelated condition that makes it harder to see things up close** Presbyopia affects most people over 45; causes blurred near vision and eye strain** Co says filing is backed by two latestage studies showing improved near vision with no serious side effects** FDA decision expected by October 17, 2026, per co** Shares down ~27% in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4N3ZL12X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4007","LU1839511570.USD","BK4585","BK4588","VTRS","BK4583"],"gpt_icon":0},{"id":"2614208921","title":"Tonix Pharmaceuticals to Participate in TD Cowen Annual Healthcare Conference and Barclays Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614208921","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614208921?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:01","pubTimestamp":1772020914,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals to Participate in TD Cowen Annual Healthcare Conference and Barclays Annual Healthcare Conference               Tonix Pharmaceuticals Holding Corp. will participate in two invest","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL6sLPVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU2210149790.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","BK4112","LU0314104364.USD","BK4588","IE00BGHQF748.EUR","BK4585","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","TNXP","SG9999014005.SGD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2614899120","title":"FDA accepts Opus Genetics sNDA for phentolamine ophthalmic solution 0.75% to treat presbyopia","url":"https://stock-news.laohu8.com/highlight/detail?id=2614899120","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614899120?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:59","pubTimestamp":1772020761,"startTime":"0","endTime":"0","summary":"Opus Genetics Inc. said the U.S. Food and Drug Administration has accepted for review its supplemental New Drug Application for phentolamine ophthalmic solution 0.75% to treat presbyopia. The agency set a PDUFA goal date of Oct. 17, 2026. The product, marketed as Ryzumvi, is currently approved in the U.S. for reversal of pharmacologically induced mydriasis, and the filing seeks to expand its indication; Viatris holds exclusive U.S. commercialization rights under a licensing agreement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL9FdXLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","IE00B3QW5Z07.USD","LU0314104364.USD","IRD","NDAQ","IE00BGHQF748.EUR","BK4112","BK4585","IE00BKPKM429.USD","LU1839511570.USD","LU2095319765.USD","BK4583","SG9999014005.SGD","BK4588","BK4007","SG9999014013.SGD","BK4139","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","LU2087621335.USD","SG9999014039.USD"],"gpt_icon":0},{"id":"2614916089","title":"FDA accepts Viatris sNDA for MR-141 presbyopia treatment review","url":"https://stock-news.laohu8.com/highlight/detail?id=2614916089","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614916089?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:59","pubTimestamp":1772020758,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has accepted Viatris Inc.’s supplemental New Drug Application for MR-141  for the treatment of presbyopia. The FDA set a PDUFA goal date of Oct. 17, 2026. The product is currently approved in the U.S. as Ryzumvi for reversal of pharmacologically induced mydriasis, and the filing seeks to expand its indication to presbyopia.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL2DHkqR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VTRS","LU2087621335.USD","BK4007","LU1839511570.USD","BK4588","BK4583"],"gpt_icon":0},{"id":"2614888220","title":"Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2614888220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614888220?lang=en_us&edition=fundamental","pubTime":"2026-02-25 18:06","pubTimestamp":1772013999,"startTime":"0","endTime":"0","summary":"Analyst Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Gilead Sciences and keeping the price target at $162.00. Tazeen Ahm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-strategic-arcellx-acquisition-and-anito-cel-pipeline-strength-underpin-buy-rating-and-162-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-strategic-arcellx-acquisition-and-anito-cel-pipeline-strength-underpin-buy-rating-and-162-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999015945.SGD","LU1037948897.HKD","SG9999015978.USD","LU1430594728.SGD","LU2089984988.USD","LU0106831901.USD","LU0170899867.USD","LU0640476718.USD","LU0965509283.SGD","LU1496350502.SGD","LU2087621335.USD","LU0648001328.SGD","BK4583","LU0203345920.USD","LU0314106906.USD","LU0868494617.USD","BAC","LU2129689605.HKD","LU0098860793.USD","BK4532","LU1894683348.USD","BK4578","LU0130102774.USD","LU0477156797.USD","SG9999015952.SGD","BK4568","LU0114720955.EUR","LU0234570918.USD","LU1791807156.HKD","LU0477156953.USD","LU0889565916.HKD","LU1674673428.USD","LU1267930227.SGD","LU0256863811.USD","BK4550","LU1366192091.USD","LU0306806265.USD","LU1496350171.SGD","BK4534","LU1585245621.USD","LU1883839398.USD","LU0882574055.USD","GILD","LU0070302665.USD","LU0208291251.USD","LU1880398471.USD","IE0001KFT4U8.USD","SG9999015986.USD","LU0149725797.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2614472928","title":"Class Action Lawsuit Targets Inovio Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2614472928","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614472928?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:58","pubTimestamp":1771973880,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Inovio Pharmaceuticals Inc. in the U.S. District Court for the Eastern District of Pennsylvania on behalf of investors who bought or acquired the company’s securities between Oct. 10, 2023 and Dec. 26, 2025. The suit alleges the company made false or misleading statements and omissions about manufacturing deficiencies tied to its CELLECTRA device and the regulatory prospects for INO-3107, including the likelihood and basis for an accelerated approval filing. Investors have until April 7, 2026 to seek appointment as lead plaintiff.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL1DZL9f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","SG9999014021.USD","BK4583","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4568","LU2210149790.SGD","SG9999014039.USD","BK4588","IE00BKPKM429.USD","BK4139","SG9999014013.SGD","LU2095319765.USD","NDAQ","SG9999014005.SGD","BK4585","BK4112"],"gpt_icon":0},{"id":"2614408723","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2614408723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614408723?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:35","pubTimestamp":1771968900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.46% to $147.64 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.77% to 6,890.07 and the Dow Jones Industrial Average  rising 0.76% to 49,174.50.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 6.14% below its 52-week high of $157.29, which the company reached on February 11th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.71% to $246.28, Pfizer Inc.  rose 0.30% to $27.14, and Abbott Laboratories  fell 0.62% to $114.58.Trading volume  eclipsed its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones News","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0234572021.USD","LU2592432038.USD","LU1935042991.SGD","IE00BN8TJ469.HKD","LU2505996681.GBP","BK4559","LU2129689431.USD","SG9999015945.SGD","LU0795875169.SGD","LU1032955483.USD","IE0002270589.USD","LU0320765646.SGD","IE0034235303.USD","IE00B4R5TH58.HKD","LU1989763690.USD","SG9999004303.SGD","LU1267930813.SGD","LU1037948541.HKD","BK4568","LU1983299246.USD","LU1571399168.USD","BK4588","LU1674673428.USD","SG9999015978.USD","LU1929549753.HKD","LU1732800096.USD","SG9999015952.SGD","LU1061106388.HKD","LU0170899867.USD","BK4566","LU2471134879.HKD","LU1778281490.HKD","LU1883839398.USD","LU1244550577.SGD","LU0965509101.SGD","LU1732799900.SGD","IE000M9KFDE8.USD","LU0912757837.SGD","LU2602419157.SGD","IE00BVYPNW00.USD","LU0234570918.USD","SG9999002232.USD","LU2750360641.GBP","LU0456855351.SGD","LU0289739699.SGD","BK4585","IE00B2B36J28.USD","LU1162221912.USD","LU1430594728.SGD","LU2468319806.SGD","LU0792757196.USD","SGXZ23171101.USD","BK4504","LU0058720904.USD","LU1221951129.SGD","SG9999001176.SGD","BK4534","LU0889566641.SGD","BK4581","BK4599","LU1721429402.USD","LU0321505868.SGD","BK4007","LU0345770308.USD","SG9999011175.SGD","LU1585245621.USD","IE00B3PB1722.GBP","LU1989763427.SGD","IE00B7SZLL34.SGD","BK4583","LU0965509010.AUD","LU2430703251.USD","BK4550","LU0345769128.USD","GILD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0122379950.USD","LU0795875086.SGD","LU1066051225.USD","LU1221951046.USD","LU2133065610.SGD","LU0868494617.USD","LU1066051811.HKD","LU1074936037.SGD","LU1496350502.SGD","LU0203345920.USD","SG9999001176.USD","LU0098860793.USD","LU0787776722.HKD","IE00B19Z3B42.SGD","LU2430703178.SGD","SG9999003800.SGD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LU2129689605.HKD","LU2471134523.USD","LU0882574055.USD","LU2347655156.SGD","LU2129689514.USD","LU1066053197.SGD","LU0203347892.USD","SGXZ41872573.SGD","LU0321505439.SGD","LU0985320562.USD","BK4533","LU0345770993.USD","SG9999001440.SGD","LU0114720955.EUR","LU0306807586.USD","SGXZ57979304.SGD","LU0683600562.USD","LU0689626769.HKD","LU0320765992.SGD","BK4578","LU0965509283.SGD","SG9999015986.USD","LU0070217475.USD","LU0432979614.USD","LU1023059063.AUD","LU1691799644.USD","LU1914381329.SGD","IE00BFXG1179.USD","LU1244550494.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0823416689.USD","LU0306806265.USD","IE00BGHQF631.EUR","LU2324357040.USD","LU0225284248.USD","LU2237957902.USD","LU1261432733.SGD","IE0002141913.USD","LU1718418525.SGD","IE0009355771.USD","SG9999013999.USD","BK4592","LU2505996509.AUD","BK4139","BK4532","IE00B42XCP33.USD","LU1032466523.USD","LU2089984988.USD","IE0001KFT4U8.USD","LU1894683264.USD","LU0889565916.HKD","IE00BVYPNV92.GBP","LU0124676726.USD","LU1244550221.USD","LU1506573853.SGD","LU1059921491.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU2471134952.CNY","LU1721429741.USD","LU2087621335.USD","LU1066051498.USD","LU1894683348.USD","LU1037948897.HKD","LU2112291526.USD","IE00BDGV0183.EUR","LU0266013472.USD","LU2211815571.USD","LU2750360997.AUD","BK4082","LU0965508806.USD","LU1196500208.SGD","LU0861579265.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU2471134796.USD","LU0640476718.USD","SG9999002224.SGD","LU0345769631.USD","LU0225771236.USD","LU0985481810.HKD","LU0466842654.USD","IE00B3T34201.USD","IE00BLSP4452.SGD","LU2237957811.SGD","IE00BZ1G4Q59.USD","LU2430703095.HKD","LU1674673691.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2614372368","title":"Gilead FY 2025 net income attributable to shareholders hits USD 8.5 billion (NM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614372368","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614372368?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:26","pubTimestamp":1771968369,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLbdM5n1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU0965508806.USD","IE00B3T34201.USD","LU0965509283.SGD","SG9999015978.USD","LU1037948541.HKD","LU2324357040.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1674673691.USD","LU1571399168.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1778281490.HKD","LU1066051498.USD","LU2112291526.USD","BK4139","LU1037948897.HKD","LU1839511570.USD","LU0965509101.SGD","LU1057294990.SGD","IE0002270589.USD","BK4578","LU0289739699.SGD","LU2089984988.USD","LU2087621335.USD","SG9999015945.SGD","IE00B7SZLL34.SGD","BK4583","LU0109394709.USD","LU1430594728.SGD","BK4585","IE00B19Z3581.USD","LU0882574055.USD","BK4550","GILD","LU1061106388.HKD","LU0058720904.USD","IE00BKVL7J92.USD","ACLX","LU0320765992.SGD","LU0122379950.USD","LU1674673428.USD","SG9999015986.USD","BK4566","LU1585245621.USD","LU0234570918.USD","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2613952711","title":"RPT-BREAKINGVIEWS-An $8 bln pharma deal prices patent fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2613952711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613952711?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"RPT-BREAKINGVIEWS-An $8 bln pharma deal prices patent fearsThe author is a Reuters Breakingviews columnist. The opinions expressed are his own.By Robert Cyran","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZJ0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","BK4585","SG9999001176.USD","LU1989772840.SGD","LU1941712348.USD","LU0787776722.HKD","LU0122379950.USD","SG9999015986.USD","LU1116320901.HKD","LU0985481810.HKD","BK4139","LU0149725797.USD","BK4532","LU0648001328.SGD","LU1720051108.HKD","LU1244550494.USD","LU1674673691.USD","LU0971096721.USD","LU2129689514.USD","LU1506573853.SGD","LU2361044949.HKD","LU0965509101.SGD","LU1267930227.SGD","LU1496350171.SGD","LU1668664300.SGD","LU0320765646.SGD","LU0234572021.USD","LU1061106388.HKD","LU0640476718.USD","SG9999014542.SGD","LU1983299246.USD","LU0098860793.USD","LU0130517989.USD","LU0477156797.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU0203347892.USD","LU1366192091.USD","LU2023250843.SGD","BK4583","LU0823416689.USD","LU0980610538.SGD","SG9999002232.USD","LU0158827781.USD","BK4592","LU2087621335.USD","BK4559","LU1989771016.USD","IE0002270589.USD","LU1934455863.HKD","BK4599","LU1201861249.SGD","LU1066051498.USD","LU2106854487.HKD","LU2111349929.HKD","SG9999015978.USD","BK4550","LU0106261372.USD","LU0211331839.USD","SG9999013999.USD","IE00B19Z3581.USD","IE0009355771.USD","IE00BBT3K403.USD","LU1057294990.SGD","LU1791807156.HKD","BK4534","IE0002141913.USD","LU0267386448.USD","LU0306807586.USD","LU0912757837.SGD","LU1201861165.SGD","LU1934455194.USD","LU1162221912.USD","LU1430594728.SGD","LU0225283273.USD","IE000M9KFDE8.USD","LU1839511570.USD","LU0256863902.USD","LU0314106906.USD","LU2271345857.HKD","LU2461242641.AUD","LU0130518102.USD","IE00BFXG1179.USD","LU0130102774.USD","LU2324357040.USD","LU0052756011.USD","LU1571399168.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0130103400.USD","BK4207","LU1037948897.HKD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LU0557290698.USD","BK4588","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU1066051811.HKD","IE00B7SZLL34.SGD","LU0106831901.USD","ACLX","LU1718418525.SGD","LU1732800096.USD","LU0985320562.USD","LU1929549753.HKD","LU1989772923.USD","SG9999014567.USD","LU1791710582.SGD","SG9999015945.SGD","LU1093756168.USD","LU0006306889.USD","LU1941712264.USD","LU0882574055.USD","BK4127","LU2129689431.USD","LU0234570918.USD","LU1280957306.USD","IE00BKVL7J92.USD","LU0528227936.USD","SG9999014575.USD","IE0034235188.USD","LU0795875169.SGD","LU0265550359.USD","LU0456855351.SGD","LU0158827948.USD","LU2023251221.USD","LU2361044865.SGD","LU1291159041.SGD","LU2112291526.USD","LU0256863811.USD","SG9999015341.SGD","LU1732799900.SGD","LU1548497426.USD","LU2360032135.SGD","SG9999001440.SGD","LU1791710400.SGD","LU2357305700.SGD","LU0208291251.USD","LU1116320737.USD","LU2125154935.USD","LU1804176565.USD","LU2361045086.USD","LU1037948541.HKD","BK4504","LU0320765489.SGD","LU2265009873.SGD","LU0889565916.HKD","BK4578","LU1894683264.USD","LU1894683348.USD","LU0648000940.SGD","LU1074936037.SGD","LU1720051017.SGD","LU0128525689.USD","LU0795875086.SGD","BK4581","LU0321505868.SGD","LU1035773651.USD","LU1917777945.USD","LU0965508806.USD","LU1093756325.SGD","LU2129689605.HKD","LU0265550946.USD","LU0683600562.USD","LU0266013472.USD","LU0432979614.USD","LU2089984988.USD","LU1066053197.SGD","BK4533","GILD","LU0306806265.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0965509010.AUD","LU2089284900.SGD","SG9999001176.SGD","LU0314104364.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","LU1883839398.USD","LU2347655156.SGD","LU1066051225.USD","SG9999014559.SGD","LU1880398554.USD","LU0170899867.USD","LU0868494617.USD","LU0238689110.USD","LU1934455277.USD","BK4568","LU0225771236.USD","LU0070302665.USD","LU0882574139.USD","LU1069347547.HKD","IE00B3T34201.USD","BK4553","LU1496350502.SGD","LU2028103732.USD","LU0053666078.USD","LU1585245621.USD","LU2089283258.USD","LU1974910355.USD","LU0109394709.USD","LU0965509283.SGD","BK4007","LU0477156953.USD","LU0203345920.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU1363072403.SGD","SG9999003800.SGD","IE00BSNM7G36.USD","LU0310800965.SGD","LU0114720955.EUR","LU1880398471.USD","SG9999002224.SGD","LU2023250504.SGD","LU1244550221.USD","LU1699723380.USD","SG9999015952.SGD","LU0861579265.USD","LU0058720904.USD","SG9999011175.SGD","IE0001KFT4U8.USD","BK4516","LU1023059063.AUD","IE00BN8TJ469.HKD","LU1674673428.USD","IE00BZ1G4Q59.USD","SG9999015358.SGD","LU0225284248.USD","BK4566","LU1244550577.SGD","LU2125154778.USD","LU0289739699.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2613674713","title":"Gilead Sciences (GILD) Receives a Buy from Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2613674713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613674713?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:36","pubTimestamp":1771933005,"startTime":"0","endTime":"0","summary":"Scotiabank analyst Louise Chen maintained a Buy rating on Gilead Sciences today and set a price target of $177.00. According to TipRanks, Chen is a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-scotiabank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-scotiabank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0965509010.AUD","LU1037948541.HKD","LU1023059063.AUD","LU1057294990.SGD","LU1061106388.HKD","LU2112291526.USD","LU0289739699.SGD","LU1037948897.HKD","LU1430594728.SGD","LU2087621335.USD","BK4532","LU0882574055.USD","LU2089984988.USD","LU0114720955.EUR","LU0058720904.USD","LU0823416689.USD","LU0965508806.USD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0861579265.USD","IE00BKVL7J92.USD","SG9999015945.SGD","BK4588","IE00B3T34201.USD","LU0965509101.SGD","SG9999015952.SGD","LU0109394709.USD","SG9999015986.USD","LU0320765992.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","LU2468319806.SGD","LU2324357040.USD","LU1571399168.USD","BK4566","LU1778281490.HKD","IE00B19Z3B42.SGD","GILD","LU1585245621.USD","IE00BZ1G4Q59.USD","BK4550","LU0122379950.USD","LU0234570918.USD","SG9999015978.USD","BK4578","LU1066051498.USD","BK4568","LU0965509283.SGD","BK4583","IE0002270589.USD"],"gpt_icon":0},{"id":"2613383752","title":"COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam","url":"https://stock-news.laohu8.com/highlight/detail?id=2613383752","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613383752?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:32","pubTimestamp":1771896727,"startTime":"0","endTime":"0","summary":"COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steamThe opinions expressed here are those of the author, a columnist for Reuters.By Jenna Greene","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL1N3ZJ0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","LU1720051108.HKD","LU2125909759.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1153585028.USD","LU1854103824.USD","LU0557290698.USD","LU0316494557.USD","BK4121","LU1623119135.USD","IE000M9KFDE8.USD","IE00B19Z8X17.USD","SG9999011175.SGD","LU2360108059.USD","IE0034235188.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","NVS","BK4583","LU0957791311.USD","BK4566","LU0114720955.EUR","LU2764263203.CNY","LU2125909916.SGD","BK4535","IE00B2B36J28.USD","LU1061106388.HKD","LU2543165471.USD","SGXZ57979304.SGD","BK4568","SG9999003800.SGD","BK4592","LU1894683348.USD","SG9999013999.USD","BK4139","LU1670627923.USD","LU2468319806.SGD","LU0868494617.USD","LU0985481810.HKD","LU2125910336.SGD","BK4550","IE00B19Z3B42.SGD","LU2089984988.USD","LU1280957306.USD","LU0456855351.SGD","LU0208291251.USD","LU1670628061.USD","LU1815333072.USD","LU2433249047.HKD","LU0289739699.SGD","IE00BKPKM429.USD","LU0306807586.USD","LU1839511570.USD","BK4581","IE00B19Z3581.USD","BK4533","IE00BBT3K403.USD","LU0070302665.USD","LU1791710582.SGD","LU1064131342.USD","LU1633808545.USD","LU1803068623.USD","IE00B19Z8W00.USD","SG9999001176.SGD","LU2211814178.USD","LU0823416689.USD","LU2264538146.SGD","LU1894683264.USD","LU0234572021.USD","LU0225771236.USD","IE0002141913.USD","LU0266013472.USD","LU1854104046.USD","LU2211815571.USD","LU2041044095.USD","LU0321505868.SGD","LU0306806265.USD","SG9999002232.USD","LU0011850046.USD","BK4585","BK4599","LU0882574055.USD","LU1291159041.SGD","LU1066053197.SGD","LU1548497426.USD","LU2125909247.SGD","LU2112291526.USD","LU0225284248.USD","BK4007","LU1720051017.SGD","LU2087621335.USD","LU1989771016.USD","IE0002270589.USD","BK4588","LU1791710400.SGD","LU2092937221.SGD","LU1923621640.USD","SG9999002224.SGD","LU0058720904.USD","LU0320765489.SGD","LU0528227936.USD","LU0096362180.USD","LU2298321311.HKD","IE00BLSP4239.USD","IE00B19Z9505.USD","LU1712237335.SGD","LU0345770308.USD","LU0321505439.SGD","LU0640476718.USD","LU1066051498.USD","LU1023059063.AUD","LU2125909593.SGD","LU2357305700.SGD","IE00BLSP4452.SGD","LU1983299246.USD","LU2720916845.USD","LU1923622291.USD","LU2764262908.HKD","BK4548","BK4534","IE0009355771.USD","LU2125910179.SGD","LU1923622614.USD","IE00BJJMRZ35.SGD","SG9999001176.USD","LU0342679015.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU0345770993.USD","IE00B1BXHZ80.USD","LU1883839398.USD","LU1988902786.USD","LU0061474960.USD","LU2764263039.SGD"],"gpt_icon":0},{"id":"2613633627","title":"Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2613633627","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613633627?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:26","pubTimestamp":1771885560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  rallied 4.62% to $1.81 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 22,627.27 and Dow Jones Industrial Average  falling 1.66% to 48,804.06.This was the stock's sixth consecutive day of gains.Inovio Pharmaceuticals Inc. closed 39.24% short of its 52-week high of $2.98, which the company achieved on September 9th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 1.38% to $245.84, Statera Biopharma Inc.  fell 50.00% to $0.00, and Pfizer Inc.  rose 1.54% to $27.06.Trading volume  remained 1.5 million below its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 23, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134952.CNY","LU2471134523.USD","LU0792757196.USD","LU2750360997.AUD","LU0098860793.USD","IE00BJJMRZ35.SGD","SG9999011175.SGD","BK4534","LU1057294990.SGD","LU0466842654.USD","BK4568","LU2347655156.SGD","LU1221951046.USD","LU0114720955.EUR","LU2505996681.GBP","BK4550","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1732799900.SGD","IE00BFTCPJ56.SGD","LU1244550494.USD","LU2471134879.HKD","LU0345769128.USD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","LU0868494617.USD","LU1074936037.SGD","LU2129689605.HKD","IE00BBT3K403.USD","LU2750360641.GBP","LU0170899867.USD","BK4585","IE00B42XCP33.USD","LU0683600562.USD","SG9999002232.USD","LU0225771236.USD","IE00BFXG1179.USD","IE00BGHQF631.EUR","LU0345769631.USD","LU0225284248.USD","LU1496350502.SGD","LU1674673691.USD","IE00B19Z3581.USD","LU1935042991.SGD","SGXZ57979304.SGD","LU1032466523.USD","LU1732800096.USD","IE00BZ1G4Q59.USD","IE0034235303.USD","LU0234572021.USD","IE00BKVL7J92.USD","LU1430594728.SGD","LU2129689514.USD","LU1061106388.HKD","LU1221951129.SGD","LU1983299246.USD","LU0689626769.HKD","IE0002141913.USD","LU1066051225.USD","LU0985481810.HKD","SG9999013999.USD","LU1066053197.SGD","LU1929549753.HKD","LU2112291526.USD","LU0795875169.SGD","IE00BSNM7G36.USD","BK4592","LU0321505868.SGD","LU1894683348.USD","LU1506573853.SGD","LU1585245621.USD","LU2129689431.USD","IE00B4R5TH58.HKD","LU1261432733.SGD","LU0432979614.USD","LU1267930813.SGD","IE00BLSP4239.USD","LU2133065610.SGD","LU0320765646.SGD","LU0345770308.USD","BK4588","LU1674673428.USD","BK4504","LU2430703178.SGD","LU0882574055.USD","LU1778281490.HKD","BK4139","IE00BVYPNW00.USD","LU1280957306.USD","SG9999003800.SGD","SG9999001176.USD","IE00B7SZLL34.SGD","IE00BDGV0183.EUR","LU0234570918.USD","LU1032955483.USD","LU2602419157.SGD","IE0002270589.USD","BK4007","INO","LU1066051498.USD","LU2089984988.USD","LU2592432038.USD","LU0456855351.SGD","IE00B3T34201.USD","SG9999002224.SGD","LU2468319806.SGD","LU1066051811.HKD","LU0070217475.USD","IE0001KFT4U8.USD","LU0889566641.SGD","BK4532","LU0203345920.USD","LU1023059063.AUD","SG9999001440.SGD","LU0122379950.USD","LU1244550221.USD","BK4533","LU0124676726.USD","LU0203347892.USD","LU2430703251.USD","LU0912757837.SGD","LU2430703095.HKD","BK4581","LU2505996509.AUD","LU0321505439.SGD","LU0289739699.SGD","BK4599","LU1162221912.USD","LU1244550577.SGD","LU0306807586.USD","IE00BVYPNV92.GBP","LU0345770993.USD","LU2471134796.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1196500208.SGD","SG9999001176.SGD","LU1718418525.SGD","LU0795875086.SGD","IE0009355771.USD","LU1059921491.USD","IE00BN8TJ469.HKD","LU0787776722.HKD","LU1883839398.USD","LU0640476718.USD","LU1914381329.SGD","BK4583","LU0058720904.USD","LU0985320562.USD","IE00BLSP4452.SGD","LU0306806265.USD","IE00BJT1NW94.SGD","BK4559"],"gpt_icon":0},{"id":"2613372767","title":"CORRECTED-Belgium's Galapagos 2025 net revenue surges, driven by Gilead collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2613372767","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613372767?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:12","pubTimestamp":1771881120,"startTime":"0","endTime":"0","summary":"CORRECTED-Belgium's Galapagos 2025 net revenue surges, driven by Gilead collaborationCorrects FY Cash & Investments figure in Key Details table to EUR 2.998 bln from -EUR 44.80 mlnOverviewBelgium-base","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL1N3ZJ10F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1839511570.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1037948897.HKD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU2468319806.SGD","BK4585","LU1430594728.SGD","LU0320765992.SGD","LU1674673691.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1037948541.HKD","LU1061106388.HKD","LU1057294990.SGD","BK4139","SG9999015986.USD","BK4583","LU0114720955.EUR","LU0122379950.USD","LU2324357040.USD","BK4578","BK4568","LU0289739699.SGD","LU2089984988.USD","SG9999015978.USD","LU0965508806.USD","LU1674673428.USD","BK4532","IE00BSNM7G36.USD","GILD","LU0889565916.HKD","LU0965509283.SGD","IE00BKVL7J92.USD","LU0965509010.AUD","LU1585245621.USD","IE00B3T34201.USD","LU2112291526.USD","LU0234570918.USD","LU1023059063.AUD","LU2087621335.USD","LU1066051498.USD","LU1571399168.USD","LU1778281490.HKD","BK4588","IE0002270589.USD"],"gpt_icon":0},{"id":"2613739427","title":"Inovio Shareholders Face April 7 Deadline in Securities Fraud Class Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2613739427","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613739427?lang=en_us&edition=fundamental","pubTime":"2026-02-24 02:07","pubTimestamp":1771870025,"startTime":"0","endTime":"0","summary":"Inovio Pharmaceuticals Inc. is facing a securities fraud class action on behalf of investors who bought the company’s securities between Oct. 10, 2023 and Dec. 26, 2025. The suit alleges the company made misleading statements and omitted key information about manufacturing deficiencies in its CELLECTRA device and the regulatory timeline and prospects for its INO-3107 treatment, including delays to a planned FDA filing and uncertainty around accelerated approval. A deadline of April 7, 2026 has been set for investors to seek appointment as lead plaintiff.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL95Shsl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","BK4568","BK4583","LU2095319765.USD","LU0314104364.USD","INO","LU2210150020.SGD","SG9999014039.USD","BK4112","SG9999014021.USD","SG9999014013.SGD","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","LU2210149790.SGD","BK4588","BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction